Cidara Therapeutics Investor Relations Material
Latest events
Q2 2025
Cidara Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cidara Therapeutics Inc
Access all reports
Cidara Therapeutics Inc. is a biotechnology company focused on developing anti-infective and immunotherapy treatments. The company specializes in long-acting antifungal and antiviral therapies, utilizing its proprietary drug-Fc conjugate (DFC) platform to enhance targeted immune responses. Its pipeline includes investigational treatments for serious fungal infections and viral diseases. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Cidara Therapeutics Inc
Corporate Presentation
Cidara Therapeutics Inc
Corporate Presentation
Cidara Therapeutics Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CDTX
Country
🇺🇸 United States